Wilms' Tumor

Pediatric Surgery: Sixth Edition

Volumn 1-2, Issue , 2006, Pages 445-466

  Tagge, Edward P ^a,b   Thomas, Patrick B ^c   Othersen, H Biemann ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883275556     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02842-4.50030-9     Document Type: Chapter

References (141)

1. Argani P, Perlman EJ, Breslow NE, et al. Clear cell sarcoma of the kidney: A review of 351 cases from the National Wilms' Tumor Study Group Pathology Center. Am J Surg Pathol 2000, 24:4-18.
2. Argenta PA, Lin RY, Sullivan KM Basic fibroblast growth factor is a Wilms' tumor marker. Surg Forum 1994, 45:789.
3. Bardeesy N, Falkoff D, Petruzzi MJ, et al. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 mutations. Nat Genet 1994, 7:91-97.
4. Bardeesy N, Zabel B, Schmitt K, et al. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics 1994, 21:663-664.
5. Barrantes JC, Muir KR, Toyn CE, et al. Thirty-year population-based review of childhood renal tumours with an assessment of prognostic features including tumour DNA characteristics. Med Pediatr Oncol 1993, 21:24-30.
6. Beckwith JB Wilms' tumor and other renal tumors of childhood: A selective review from the National Wilms' Tumor Study Pathology Center. Hum Pathol 1983, 14:481-492.
7. Beckwith JB Precursor lesions of Wilms' tumor: Clinical and biological implications. Med Pediatr Oncol 1993, 21:158-168.
8. Beckwith JB Nephrogenic rests and the pathogenesis of Wilms' tumor: Developmental and clinical considerations. Am J Med Genet 1998, 79:268-273.
9. Beckwith JB, Kiviat NB, Bonadio JF Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 1990, 10:1-36.
10. Beckwith JB, Palmer NF Histopathology and prognosis of Wilms' tumors: Results from the First National Wilms' Tumor Study. Cancer 1978, 41:1937-1948.
11. Bishop HC, Tefft M, Evans AE, et al. Survival in bilateral Wilms' tumor review of 30 National Wilms' Tumor Study cases. J Pediatr Surg 1977, 12:631-638.
12. Blann AD, Li JL, Li C, et al. Increased serum VEGF in 13 children with Wilms' tumour falls after surgery but rising levels predict poor prognosis. Cancer Lett 2001, 173:183-186.
13. Blute ML, Kelalis PP, Offord KP, et al. Bilateral Wilms' tumor. J Urol 1987, 138:968-973.
14. Bonadio JF, Storer B, Norkool P, et al. Anaplastic Wilms' tumor: Clinical and pathologic studies. J Clin Oncol 1985, 3:513-520.
15. Bown N, Cotterill SJ, Roberts P, et al. Cytogenetic abnormalities and clinical outcome in Wilms' tumor: A study by the UK Cancer Cytogenetics Group and the UK Children's Cancer Study Group. Med Pediatr Oncol 2002, 38:11-21.
16. Breslow N, Olshan A, Beckwith JB, et al. Epidemiology of Wilms' tumor. Med Pediatr Oncol 1993, 21:172-181.
17. Breslow NE, Norris R, Norkool PA, et al. Characteristics and outcomes of children with the Wilms' tumor-aniridia syndrome: A report from the National Wilms' Tumor Study Group. J Clin Oncol 2003, 21:4579-4585.
18. Breslow NE, Olson J, Moksness J, et al. Familial Wilms' tumor: A descriptive study. Med Pediatr Oncol 1996, 27:398-403.
19. Bunin GR, Meadows AT Epidemiology and Wilms' tumor: Approaches and methods. Med Pediatr Oncol 1993, 21:169-171.
20. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990, 60:509-520.
21. Canning DA Is partial nephrectomy appropriate treatment for unilateral Wilms' tumor?. J Urol 1999, 161:367.
22. Capra ML, Walker DA, Mohammed WM, et al. Wilms' tumor: A 25-year review of the role of preoperative chemotherapy. J Pediatr Surg 1999, 34:579-582.
23. Chiappini B, Savini C, Marinelli G, et al. Cavoatrial tumor thrombus: Single-stage surgical approach with profound hypothermia and circulatory arrest, including a review of the literature. J Thorac Cardiovasc Surg 2002, 124:684-688.
24. Choyke PL, Siegel MJ, Craft AW, et al. Screening for Wilms' tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 1999, 32:196-200.
25. Clayman RV, Sheldon CA, Gonzales R Wilms' tumor: An approach to vena caval intrusion. Prog Pediatr Surg 1983, 15:285-290.
26. Cooper CS, Jaffe WI, Huff DS, et al. The role of renal salvage procedures for bilateral Wilms' tumor: A 15-year review. J Urol 2000, 163:265-268.
27. Coppes MJ, Arnold M, Beckwith JB, et al. Factors affecting the risk of contralateral Wilms' tumor development: A report from the National Wilms' Tumor Study Group. Cancer 1999, 85:1616-1625.
28. Coppes MJ, Bonetta L, Huang A, et al. Loss of heterozygosity mapping in Wilms' tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination. Genes Chromosomes Cancer 1992, 5:326-334.
29. Coppes MJ, de Kraker J, van Dijken PJ, et al. Bilateral Wilms' tumor: Long-term survival and some epidemiological features. J Clin Oncol 1989, 7:310-315.
30. Coppes MJ, Haber DA, Grundy PE Genetic events in the development of Wilms' tumor. N Engl J Med 1994, 331:586-590.
31. Coppes MJ, Huff V, Pelletier J Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr 1993, 123:673-678.
32. Coppes MJ, Pritchard-Jones K Principles of Wilms' tumor biology. Urol Clin North Am 2000, 27:423-433.
33. Cosentino CM, Raffensperger JG, Luck SR, et al. A 25-year experience with renal tumors of childhood. J Pediatr Surg 1993, 28:1350-1355.
34. Crist WM, Kun LE Common solid tumors of childhood. N Engl J Med 1991, 324:461-471.
35. D'Angio GJ, Breslow N, Beckwith JB, et al. Treatment of Wilms' tumor: Results of the Third National Wilms' Tumor Study. Cancer 1989, 64:349-360.
36. D'Angio GJ, Evans AE, Breslow N, et al. The treatment of Wilms' tumor: Results of the National Wilms' Tumor Study. Cancer 1976, 38:633-646.
37. D'Angio GJ, Evans A, Breslow N, et al. The treatment of Wilms' tumor: Results of the Second National Wilms' Tumor Study. Cancer 1981, 47:2302-2311.
38. Davidoff AM, Nathwani AC, Spurbeck WW, et al. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice. Cancer Res 2002, 62:3077-3083.
39. Davies-Johns T, Chidel M, Macklis RM The role of radiation therapy in the management of Wilms' tumor. Semin Urol Oncol 1999, 17:46-54.
40. de Kraker J, Voute PA, Lemerle J, et al. Preoperative chemotherapy in Wilms' tumour: Results of clinical trials and studies on nephroblastomas conducted by the International Society of Paediatric Oncology (SIOP). Prog Clin Biol Res 1982, 100:131-144.
41. Desai D, Nicholls G, Duffy PG Bench surgery with autotransplantation for bilateral synchronous Wilms' tumor: A report of three cases. J Pediatr Surg 1999, 34:632-634.
42. Dome JS, Liu T, Krasin M, et al. Improved survival for patients with recurrent Wilms' tumor: The experience at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol 2002, 24:192-198.
43. Donckerwolcke RM, Coppes MJ Adaptation of renal function after unilateral nephrectomy in children with renal tumors. Pediatr Nephrol 2001, 16:568-574.
44. Eberth DJ Myoma sarcomatodes renum. Virchows Arch Pathol Anat Physiol 1872, 10:518-521.
45. Egeler RM, Wolff JE, Anderson RA, et al. Long-term complications and post-treatment follow-up of patients with Wilms' tumor. Semin Urol Oncol 1999, 17:55-61.
46. Eggert A, Grotzer MA, Ikegaki N, et al. Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor. J Clin Oncol 2001, 19:689-696.
47. Farber S Chemotherapy in the treatment of leukemia and Wilms' tumor. JAMA 1966, 198:826-836.
48. Faria P, Beckwith JB, Mishra K, et al. Focal versus diffuse anaplasia in Wilms' tumor new definitions with prognostic significance: A report from the National Wilms' Tumor Study Group. Am J Surg Pathol 1996, 20:909-920.
49. Federici S, Galli G, Ceccarelli PL, et al. Wilms' tumor involving the inferior vena cava: Preoperative evaluation and management. Med Pediatr Oncol 1994, 22:39-44.
50. Friedlander A Sarcoma of the kidney treated by roentgen ray. Am J Dis Child 1916, 12:328-331.
51. Gessler M, Konig A, Arden K, et al. Infrequent mutation of the WT1 gene in 77 Wilms' tumors. Hum Mutat 1994, 3:212-222.
52. Gessler M, Poustka A, Cavenee W, et al. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990, 343:774-778.
53. Ghanem MA, Van der Kwast TH, Den Hollander JC, et al. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma. Br J Cancer 2001, 85:1557-1563.
54. Godzinski J, Tournade MF, de Kraker J, et al. The role of preoperative chemotherapy in the treatment of nephroblastoma: The SIOP experience. Societe Internationale d'Oncologie Pediatrique. Semin Urol Oncol 1999, 17:28-32.
55. Goske MJ, Mitchell C, Reslan WA Imaging of patients with Wilms' tumor. Semin Urol Oncol 1999, 17:11-20.
56. Graf N, Tournade MF, de Kraker J The role of preoperative chemotherapy in the management of Wilms' tumor: The SIOP studies. International Society of Pediatric Oncology. Urol Clin North Am 2000, 27:443-454.
57. Green DM, D'Angio G, J, Beckwith B, et al. Wilms' tumor (nephroblastoma, renal embryoma). Principles and Practices of Pediatric Oncology 1993, 713-738. JB Lippincott, Philadelphia. 2nd ed. P.A. Pizzo, D.G. Poplack (Eds.).
58. Green DM, Beckwith JB, Breslow NE, et al. Treatment of children with stages II to IV anaplastic Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 1994, 12:2126-2131.
59. Green DM, Breslow NE, Beckwith JB, et al. Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: A report from the National Wilms' Tumor Study. J Clin Oncol 1993, 11:91-95.
60. Green DM, Breslow NE, Beckwith JB, et al. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 1998, 16:237-245.
61. Green DM, Breslow NE, Beckwith JB, et al. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 1998, 16:3744-3751.
62. Green DM, Grigoriev YA, Nan B, et al. Congestive heart failure after treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 2001, 19:1926-1934.
63. Green DM, Jaffe N The role of chemotherapy in the treatment of Wilms' tumor. Cancer 1979, 44:52-57.
64. Green DM, Peabody EM, Nan B, et al. Pregnancy outcome after treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 2002, 20:2506-2513.
65. Green DM, Zevon MA, Reese PA, et al. Second malignant tumors following treatment during childhood and adolescence for cancer. Med Pediatr Oncol 1994, 22:1-10.
66. Gronskov K, Olsen JH, Sand A, et al. Population-based risk estimates of Wilms' tumor in sporadic aniridia: A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia. Hum Genet 2001, 109:11-18.
67. Grundy P, Koufos A, Morgan K, et al. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Nature 1988, 336:374-376.
68. Grundy P, Telzerow PE, Paterson MC, et al. Chromosome 11 uniparental isodisomy predisposing to embryonal neoplasms. Lancet 1991, 338:1079-1080.
69. Grundy PE, Telzerow PE, Breslow N, et al. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 1994, 54:2331-2333.
70. Gururangan S, Dorman A, Ball R, et al. DNA quantitation of Wilms' tumour (nephroblastoma) using flow cytometry and image analysis. J Clin Pathol 1992, 45:498-501.
71. Henry I, Bonaiti-Pellie C, Chehensse V, et al. Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 1991, 351:665-667.
72. Henry I, Grandjouan S, Couillin P, et al. Tumor-specific loss of 11p15.5 alleles in del 11p13 Wilms' tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci U S A 1989, 86:3247-3251.
73. Hing S, Lu YJ, Summersgill B, et al. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol 2001, 158:393-398.
74. Hogeboom CJ, Grosser SC, Guthrie KA, et al. Stature loss following treatment for Wilms' tumor. Med Pediatr Oncol 2001, 36:295-304.
75. Hu M, Zhang GY, Arbuckle S, et al. Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene. Nephrol Dial Transplant 2004, 19:223-226.
76. Huang EY, Mascarenhas L, Mahour GH Wilms' tumor and horseshoe kidneys: A case report and review of the literature. J Pediatr Surg 2004, 39:207-212.
77. Huff V, Compton DA, Chao LY, et al. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13. Nature 1988, 336:377-378.
78. Huff V, Reeve AE, Leppert M, et al. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor. Cancer Res 1992, 52:6117-6120.
79. Jenkner A, Camassei FD, Boldrini R, et al. 111 Renal neoplasms of childhood: A clinicopathologic study. J Pediatr Surg 2001, 36:1522-1527.
80. Kalapurakal JA, Peterson S, Peabody EM, et al. Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms' tumor survivors: A report from the National Wilms' Tumor Study. Int J Radiat Oncol Biol Phys 2004, 58:1364-1368.
81. Kayton ML, Rowe DH, O'Toole KM, et al. Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor. J Pediatr Surg 1999, 34:743-747.
82. Knudson AG, Strong LC Mutation and cancer: A model for Wilms' tumor of the kidney. J Natl Cancer Inst 1972, 48:313-324.
83. Ladd WE, White RR Embryoma of the kidney (Wilms' tumor). JAMA 1941, 117:1859-1863.
84. Leape LL, Breslow NE The surgical treatment of Wilms' tumor: Results of the National Wilms' Tumor Study. Ann Surg 1978, 187:351-356.
85. Lee MP, DeBaun MR, Mitsuya K, et al. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLZT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc Natl Acad Sci U S A 1999, 96:5203-5208.
86. Lee SB, Haber DA Wilms' tumor and the WT1 gene. Exp Cell Res 2001, 264:74-99.
87. Li CM, Guo M, Borczuk A, et al. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 2002, 160:2181-2190.
88. Lin RY, Argenta PA, Sullivan KM, et al. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients. Clin Cancer Res 1995, 1:327-331.
89. Little MH, Williamson KA, Mannens M, et al. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet 1993, 2:259-264.
90. Lodge AJ, Jaggers J, Adams D, et al. Vascular control for resection of suprahepatic intracaval Wilms' tumor: Technical considerations. J Pediatr Surg 2000, 35:1836-1837.
91. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma. A Pediatric Oncology Group Study. J Clin Oncol 1991, 9:581-591.
92. Lovvorn HN, Savani RC, Ruchelli E, et al. Serum hyaluronan and its association with unfavorable histology and aggressiveness of heterotransplanted Wilms' tumor. J Pediatr Surg 2000, 35:1070-1078.
93. Lu YJ, Hing S, Williams R, et al. Chromosome 1q expression profiling and relapse in Wilms' tumour. Lancet 2002, 360:385-386.
94. Marsden HB, Lawler W Bone-metastasizing renal tumor of childhood. Br J Cancer 1978, 38:437-441.
95. Maw MA, Grundy P, Millow LJ, et al. A third Wilms' tumor locus on chromosome 16q. Cancer Res 1992, 52:3094-3098.
96. McNeil DE, Brown M, Ching A, et al. Screening for Wilms' tumor and hepatoblastoma in children with Beckwith-Wiedemann syndrome: A cost-effective model. Med Pediatr Oncol 2001, 37:349-356.
97. Mertens A, Neglia J, Yasui Y, et al. Mortality rates and causes of death among 5-year survivors of childhood and adolescent cancer. Proc Am Soc Clin Oncol 1999, 19:569a.
98. Miller RW, Fraumeni JG, Manning MD Association of Wilms' tumor with aniridia, hemihypertrophy and other congenital abnormalities. N Engl J Med 1964, 270:922-930.
99. Mitchell C, Jones PM, Kelsey A, et al. The treatment of Wilms' tumour: Results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study. Br J Cancer 2000, 83:602-608.
100. Montgomery BT, Kelalis PP, BLute ML, et al. Extended followup of bilateral Wilms' tumor: Results of the National Wilms' Tumor Study. J Urol 1991, 146:514-518.
101. Narahara K, Kikkawa K, Kimira S, et al. Regional mapping of catalase and Wilms' tumor-aniridia, genitourinary abnormalities, and mental retardation triad loci to the chromosome segment 11p1305-p1306. Hum Genet 1984, 66:181-185.
102. Neville H, Ritchey ML, Shamberger RC, et al. The occurrence of Wilms' tumor in horseshoe kidneys: A report from the National Wilms' Tumor Study Group (NWTSG). J Pediatr Surg 2002, 37:1134-1137.
103. Okutsu T, Kuroiwa Y, Kagitani F, et al. Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors. J Biochem 2000, 127:475-483.
104. Osler W Two cases of striated myo-sarcoma of the kidney. J Anat Physiol 1879, 14.
105. Owens CM, Veys PA, Pritchard J, et al. Role of chest computed tomography at diagnosis in the management of Wilms' tumor: A study by the United Kingdom Children's Cancer Study Group. J Clin Oncol 2002, 20:2768-2773.
106. Pappo AS, Crist WM, Kuttesch J, et al. Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. J Clin Oncol 1993, 11:1901-1905.
107. Park S, Bernard A, Bove KE, et al. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nat Genet 1993, 5:363-367.
108. Pelletier J, Bruening W, Kashtan CE, et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991, 67:437-447.
109. Pelletier J, Bruening W, Li FP, et al. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 1991, 353:431-434.
110. Plesko I, Kramarova E, Stiller CA, et al. Survival of children with Wilms' tumour in Europe. Eur J Cancer 2001, 37:736-743.
111. Porteus MH, Narkool P, Neuberg D, et al. Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 2000, 18:2026-2031.
112. Rahman N, Arbour L, Houlston R, et al. Penetrance of mutations in familial Wilms' tumor gene FW1. J Natl Cancer Inst 2000, 96:650-652.
113. Re GG, Hazen-Martin DJ, Sens DA, et al. Nephroblastoma (Wilms' tumor): A model system of aberrant renal development. Semin Diagn Pathol 1994, 11:126-135.
114. Reeve AE, Sih SA, Raizis AM, et al. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol 1989, 9:1799-1803.
115. Renaud EJ, Liu D, Pipe SW, et al. Inferior vena cavectomy for nonexcisable Wilms' tumor thrombus. J Pediatr Surg 2001, 36:526-529.
116. Riccardi VM, Sujansky E, Smith AC, et al. Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 1978, 61:604-610.
117. Ritchey ML The role of preoperative chemotherapy for Wilms' tumor: The NWTSG perspective. National Wilms' Tumor Study Group. Semin Urol Oncol 1999, 17:21-27.
118. Ritchey ML, Green DM, Thomas PR, et al. Renal failure in Wilms' tumor patients: A report from the National Wilms' Tumor Study Group. Med Pediatr Oncol 1996, 26:75-80.
119. Ritchey ML, Kelalis PP, Breslow N, et al. Surgical complications after nephrectomy for Wilms' tumor. Surg Gynecol Obstet 1992, 1992:507-514.
120. Ritchey ML, Kelalis PP, Haase GM, et al. Preoperative therapy for intracaval and atrial extension of Wilms' tumor. Cancer 1993, 71:4104-4110.
121. Ritchey ML, Pringle K, Breslow N, et al. Management and outcome of inoperable Wilms' tumor: A report of National Wilms' Tumor Study-3. Ann Surg 1994, 220:683-690.
122. Ritchey ML, Shamberger RC, Haase G, et al. Surgical complications after primary nephrectomy for Wilms' tumor: Report from the National Wilms' Tumor Study Group. J Am Coll Surg 2001, 192:63-68.
123. Ross JH, Kay R Surgical considerations for patients with Wilms' tumor. Semin Urol Oncol 1999, 17:33-39.
124. Shamberger RC, Guthrie KA, Ritchey ML, et al. Surgery-related factors and local recurrence of Wilms' tumor in National Wilms' Tumor Study 4. Ann Surg 1999, 229:292-297.
125. Shamberger RC, Ritchey ML, Haase GM, et al. Intravascular extension of Wilms' tumor. Ann Surg 2001, 234:116-121.
126. Shearer P, Kapoor G, Beckwith JB, et al. Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: A report from the National Wilms' Tumor Study Group. J Pediatr Hematol Oncol 2001, 23:109-111.
127. Shurin SB, Gauderer MW, Dahms BB, et al. Fatal intraoperative pulmonary embolization of Wilms' tumor. J Pediatr 1982, 101:559-562.
128. Smith MB, Xue H, Strong LC, et al. Forty-year experience with second malignancies after treatment of childhood cancer: Analysis of outcome following the development of the second malignancy. J Pediatr Surg 1993, 28:1342-1348.
129. Sorensen K, Levitt GA, Bull C, et al. Late anthracycline cardiotoxicity after childhood cancer: A prospective longitudinal study. Cancer 2003, 97:1991-1998.
130. Sredni ST, de Camargo B, Lopes LF, et al. Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms' tumor. Med Pediatr Oncol 2001, 37:455-458.
131. Tagge EP, Hanson P, Re GG, et al. Paired box gene expression in Wilms' tumor. J Pediatr Surg 1994, 29:134-141.
132. Toretsky JA, Zitomersky NL, Eskenazi AE, et al. Glypican-3 expression in Wilms' tumor and hepatoblastoma. J Pediatr Hematol Oncol 2001, 23:496-499.
133. Tournade MF, Com-Nougue C, de Kraker J, et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: Results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 2001, 19:488-500.
134. Trueworthy R, Shuster JJ, Look T, et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group Study. J Clin Oncol 1992, 10:606-613.
135. Vujanic GM, Kelsey A, Mitchell C, et al. The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms' tumor study 3. Med Pediatr Oncol 2003, 40:18-22.
136. Vujanic GM, Sandstedt B, Harms D, et al. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol 2002, 38:79-82.
137. Weeks DA, Beckwith JB, Mierau GW, et al. Rhabdoid tumor of kidney: A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol 1989, 13:439-458.
138. White GR, Kelsey AM, Varley JM, et al. Somatic glypican 3 (GPC3) mutations in Wilms' tumour. Br J Cancer 2002, 86:1920-1922.
139. Wilms M: Die Mischgeschwuelste der Niere. In Leipzig, 1899, Arthur Georgi.
140. Zoeller G, Pekrun A, Lakomek M, et al. Wilms' tumor: The problem of diagnostic accuracy in children undergoing preoperative chemotherapy without histological tumor verification. J Urol 1994, 151:169-171.
141. Zuppan CW, Beckwith JB, Luckey DW Anaplasia in unilateral Wilms' tumor: A report from the National Wilms' Tumor Study Pathology Center. Hum Pathol 1988, 19:1199-1209.